Mirae Asset Global Etfs Holdings Ltd. Rapt Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 17,073 shares of RAPT stock, worth $19,292. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,073
Previous 16,313
4.66%
Holding current value
$19,292
Previous $32,000
18.75%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RAPT
# of Institutions
100Shares Held
124MCall Options Held
246KPut Options Held
69.6K-
Medicxi Ventures Management (Jersey) LTD22.4MShares$25.3 Million7.76% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$14.8 Million3.39% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$14.8 Million0.56% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$14.1 Million8.8% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$13.3 Million0.3% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $33.5M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...